|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007137,
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0205179,
umls-concept:C0205420,
umls-concept:C0332283,
umls-concept:C0460004,
umls-concept:C0600558,
umls-concept:C1122962,
umls-concept:C1517927,
umls-concept:C1522449
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-5-4
|
|
pubmed:abstractText |
The authors evaluated the feasibility, toxicity, and efficacy of gefitinib added to first-line combined-modality therapy for patients with locally advanced squamous carcinoma of the head and neck.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2138-46
|
|
pubmed:meshHeading |
pubmed-meshheading:19288572-Adult,
pubmed-meshheading:19288572-Aged,
pubmed-meshheading:19288572-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19288572-Carboplatin,
pubmed-meshheading:19288572-Carcinoma, Squamous Cell,
pubmed-meshheading:19288572-Combined Modality Therapy,
pubmed-meshheading:19288572-Female,
pubmed-meshheading:19288572-Fluorouracil,
pubmed-meshheading:19288572-Head and Neck Neoplasms,
pubmed-meshheading:19288572-Humans,
pubmed-meshheading:19288572-Male,
pubmed-meshheading:19288572-Middle Aged,
pubmed-meshheading:19288572-Neoadjuvant Therapy,
pubmed-meshheading:19288572-Quinazolines,
pubmed-meshheading:19288572-Remission Induction,
pubmed-meshheading:19288572-Taxoids,
pubmed-meshheading:19288572-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck.
|
|
pubmed:affiliation |
Sarah Cannon Research Institute, Nashville, Tennessee, USA. jhainsworth@tnonc.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
